Potential US pharma import tariffs could raise prices, stifle innovation, and revolutionise how the industry produces drugs.

AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...

The head of drugmaker Eli Lilly, which sells the popular weight-loss drug Zepbound, urged the Trump administration to ease up on its tariff rollout because it could hurt Lilly’s business and the ...

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.

While Big Pharma seems ready to weather the tariff storm, independent pharmacists and makers of generic drugs — which account for 90% of U.S. prescriptions — see trouble ahead for patients.

The Trump administration wants to bring the production of more drugs, including medicines like antibiotics that may be in ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...